Diebold Nixdorf, Incorporated DBD

Full chart Compare
Set alert

Price alert · DBD

All alert types
56.88 USD -1.10 (-1.90%)

Nov 5, 2026, 1:30 PM EST

56.10 Day range 57.89
52.87 52-week range 92.09
YTD
-16.22%
1 year
-10.06%

Revenue & Expenses

Revenue → Gross Profit: $961.20MGross Profit → Net Income: $94.60MGross Profit → Selling, General & Admin: $632.50MRevenue → Cost of Revenue: $2.84BGross Profit → Research & Development: $86.70MGross Profit → Interest Expense: $85.70MGross Profit → Other Expenses: $37.60MGross Profit → Income Tax: $24.10MGross Profit$961.20MCost of Revenue$2.84BNet Income$94.60MSelling, General & Admin$632.50MResearch & Development$86.70MInterest Expense$85.70MOther Expenses$37.60MIncome Tax$24.10MRevenue$3.81B

Latest period ending Dec 31, 2025 · select a line to chart its full history

DBD annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.81B3.75B3.46B3.91B
961.20M920.00M757.30M1.04B
242.00M182.10M-211.70M137.10M
94.60M-16.50M-581.40M-78.80M
2.54-0.44-7.36-1.01
DBD annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
387.30M311.30M319.10M—
3.85B3.54B3.06B—
2.75B2.61B4.44B—
938.50M927.30M2.73B—
1.10B929.80M-1.38B—
DBD annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
300.70M149.20M-387.90M123.30M
-97.60M-45.50M-23.80M-49.20M
-143.90M-366.50M349.80M-3.60M
-61.70M-40.40M-47.10M-49.60M
76.00M-281.00M-70.10M64.80M